Show simple item record

dc.contributor.authorde Gier, Brechje
dc.contributor.authorAndeweg, Stijn
dc.contributor.authorJoosten, Rosa
dc.contributor.authorTer Schegget, Ronald
dc.contributor.authorSmorenburg, Naomi
dc.contributor.authorvan de Kassteele, Jan
dc.contributor.authorHahné, Susan Jm
dc.contributor.authorvan den Hof, Susan
dc.contributor.authorde Melker, Hester E
dc.contributor.authorKnol, Mirjam J
dc.date.accessioned2021-09-22T07:18:44Z
dc.date.available2021-09-22T07:18:44Z
dc.identifier.pmid34355689
dc.identifier.doi10.2807/1560-7917.ES.2021.26.31.2100640
dc.identifier.urihttp://hdl.handle.net/10029/625286
dc.language.isoenen_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2en_US
dc.subjecthousehold studyen_US
dc.subjecttransmissionen_US
dc.subjectvaccine effectivenessen_US
dc.titleVaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.en_US
dc.typeArticleen_US
dc.identifier.eissn1560-7917
dc.identifier.journalEuro Surveill 2021; 26(31):pii.2100640en_US
dc.source.journaltitleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
dc.source.volume26
dc.source.issue31
dc.source.countrySweden


This item appears in the following Collection(s)

Show simple item record